Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
BDZ, thanks for the feeback.....I know that Apelbetalone targets CVD, but its kind of tricky explaining that the trial is for Diabetic Mellitus patients - but in effect its seeking to treat CVD....I kind of view it as doing an end around or looking for a loop hole.
Thanks for the comprehensive view on why ESPR went from such a high to its current levels.
